Taking LIVMARLI | LIVMARLI® (maralixibat) Patient Site

Two convenient options. One small dose daily.

The only ileal bile acid transporter (IBAT) inhibitor available as a tablet or a liquid (oral solution) medicine.

Both LIVMARLI tablets and liquid medicine are taken by mouth.

Tablet

Tablets come in 4 fixed doses:

Tablets and dime not actual size. Dime shown for scale.

Liquid

Take directly from the measuring device delivered with your medicine.

LIVMARLI bottle and measuring device not actual size.

One dose, once per day
Both LIVMARLI tablets and liquid medicine should be taken once daily at the dosage prescribed. Take LIVMARLI 30 minutes before a meal in the morning.

Importance of weight-based dosing

Your doctor will prescribe the right dose of LIVMARLI for you
The dose of LIVMARLI you take depends on—and changes with—your weight
It is important to tell your doctor and your Mirum Access Plus Navigator about any weight changes throughout treatment with LIVMARLI
Never change the amount of LIVMARLI without first talking to your doctor

What happens if a dose is missed?

If you miss a dose within 12 hours of the time you normally take it, take LIVMARLI as soon as possible. Then take your next dose at the usual time
If a dose is missed by more than 12 hours, skip the dose and continue your original dosing schedule the next day

Staying on track
Staying on therapy, even after you start to feel relief from your cholestatic pruritus, can help ensure consistent benefit from your medicine.

You’re not alone

Whether it’s side effects, routine challenges, or cost—your care team can help. Reach out to your doctor and Mirum Access Plus Navigator to share your concerns and discuss your options.

For more information, please read the Instructions for Use.

Here are a few things to discuss with your doctor when starting LIVMARLI:
- Ask your doctor to explain how LIVMARLI works and how to know if it’s working for you or your child
- How to measure your prescribed dose of LIVMARLI liquid medicine
- How you’re feeling after starting LIVMARLI
- Discuss with your doctor about any improvements you notice, as well as any possible side effects you may have and how to manage them
Don’t stop or change the dose on your own without talking to your doctor first.

"Knowing how LIVMARLI works to reduce my bile acids and my itching, it's important for me to take it every day."

—Emma, living with Alagille syndrome

Hear from Emma and Abby—2 real people living with cholestatic pruritus—on the importance of consistent dosing with LIVMARLI. Watch Emma and Abby's full video.

Not all patients taking LIVMARLI and their caregivers will have the same experiences.

Indication

LIVMARLI (maralixibat) oral solution and tablets are a prescription medicine used to treat cholestatic pruritus (itch) in patients who are 3 months of age and older with Alagille syndrome.

It is not known if LIVMARLI is safe and effective in children with Alagille syndrome who are under 3 months of age. It is not known if LIVMARLI is safe and effective in adults who are 65 years of age and older.

Please see full Prescribing Information, including Patient Information and Instructions for Use, for LIVMARLI.

Important Safety Information

What are the possible side effects of LIVMARLI (maralixibat) oral solution and tablets?

LIVMARLI can cause serious side effects, including:

Liver injury. Changes in certain liver tests are common in patients but may worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your health care provider should do blood tests and physical exams before starting and during treatment to check your liver function. Tell your health care provider right away if you get any signs or symptoms of liver problems, including:
- nausea or vomiting
- your skin or the white part of your eye turns yellow
- dark or brown urine
- pain on the right side of your stomach (abdomen)
- fullness, bloating, or fluid in your stomach area (ascites)
- loss of appetite
- bleeding or bruising more easily than normal, including vomiting blood
Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea and stomach pain during treatment. Diarrhea can also cause the loss of too much body fluid (severe dehydration). Your health care provider may advise you to monitor for new or worsening stomach problems, including stomach pain, diarrhea, blood in your stool, or vomiting. Tell your health care provider right away if you have any new or worsening signs or symptoms of stomach and intestinal problems, including:
- diarrhea
- more frequent bowel movements than usual
- stools that are black, tarry, or sticky, or have blood or mucous
- severe stomach-area pain or tenderness
- vomiting
- urinating less often than usual
- dizziness
- headache
A condition called Fat-Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamin A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your health care provider should do blood tests before starting and during treatment, and may monitor for bone fractures and bleeding, which are common side effects.

Tell your health care provider about all medicines that you take, as LIVMARLI may interact with other medicines. If you take a medicine that lowers cholesterol by binding bile acids, such as cholestyramine, colesevelam, or colestipol, take LIVMARLI at least 4 hours before or 4 hours after you take that medicine.

Your health care provider may change your dose, or temporarily or permanently stop treatment if you have certain side effects.

LIVMARLI is available in oral solution and tablet formulations. LIVMARLI is taken by mouth, 1 time each day, 30 minutes before a meal in the morning. For the oral solution, be sure to use the provided oral dosing dispenser to accurately measure the dose of medicine.

These are not all of the possible side effects of LIVMARLI. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information and Instructions for Use, for LIVMARLI.